16:54 EST Xeris Biopharma (XERS) files $250M mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XERS:
- Xeris Biopharma reports Q4 EPS (3c), consensus (2c)
- Xeris Biopharma sees FY25 revenue $255M-$275M, consensus $239.77M
- XERS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Xeris Pharmaceuticals Appoints New Chief Medical Officer
- Xeris Biopharma CEO Ken Johnson to retire, Anh Nguyen to succeed
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue